Plant ID: NPO26213
Plant Latin Name: Tephrosia vogelii
Taxonomy Genus: Tephrosia
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
1157238
Plant-of-the-World-Online:
520509-1
Ghana; Chad; Guinea; Gabon; Mali; Nigeria; Cameroon; Sierra Leone; Benin
CA2; CA14; CA7; CA12; | |
TYR; | |
HSD17B2; | |
AHR; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Enzyme_unclassified | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Oxidoreductase | TYR | Tyrosinase | P14679 | CHEMBL1973 |
Transcription Factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.161E-10 | 1.264E-06 | CA12, CA14, CA2, CA7 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 5.080E-10 | 3.688E-06 | CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.144E-08 | 4.150E-05 | CA12, CA14, CA2, CA7 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 2.193E-08 | 6.233E-05 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 3.222E-07 | 4.153E-04 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 3.222E-07 | 4.153E-04 | CYP1A1, CYP1A2, CYP1B1 |
MF | GO:0005488; binding | GO:0020037; heme binding | 8.739E-07 | 9.062E-04 | CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 1.061E-06 | 1.050E-03 | CA2, CA7 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.293E-06 | 1.173E-03 | CA12, CA2, CA7 |
BP | GO:0008152; metabolic process | GO:0018894; dibenzo-p-dioxin metabolic process | 2.121E-06 | 1.575E-03 | CYP1A1, CYP1A2 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 2.131E-06 | 1.575E-03 | CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 2.561E-06 | 1.799E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 7.208E-06 | 4.614E-03 | CYP1A1, CYP1A2, CYP1B1, CYP2A6, HSD17B2, TYR |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 7.417E-06 | 4.614E-03 | CYP1A1, CYP2A6 |
BP | GO:0008152; metabolic process | GO:0050665; hydrogen peroxide biosynthetic process | 9.886E-06 | 5.980E-03 | CYP1A1, CYP1A2 |
BP | GO:0051179; localization | GO:2001225; regulation of chloride transport | 1.588E-05 | 9.344E-03 | CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.760E-10 | 4.225E-09 | CA12, CA2, CA7, CA14 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 3.097E-08 | 3.717E-07 | CYP1A2, HSD17B2, CYP1A1, CYP1B1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 7.907E-08 | 6.326E-07 | CYP2A6, CYP1A2, CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.267E-07 | 7.602E-07 | CYP2A6, CYP1A2, CYP1A1, CYP1B1 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.610E-06 | 7.729E-06 | CYP1A2, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 3.184E-06 | 1.130E-05 | HSD17B2, CYP1A1, CYP1B1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 7.059E-06 | 2.118E-05 | CYP2A6, CYP1A2, CYP1A1 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 4.965E-04 | 1.324E-03 | CYP2A6, HSD17B2, CYP1A2, CYP1A1, TYR |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 7.571E-04 | 1.817E-03 | CYP2A6, CYP1A2 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 3.297E-06 | 1.130E-05 | CYP2A6, CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Multiple myeloma | C90 | AHR; |
L00-L99: Diseases of the skin and subcutaneous tissue | Vitiligo | L80 | TYR; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | TYR; |
L00-L99: Diseases of the skin and subcutaneous tissue | Melasma | L81.1 | TYR; |
C00-D49: Neoplasms | Melanoma | C43 | TYR; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
NA: NA | Edema | NA | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
NA: NA | HIV infections | NA | AHR; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |